Featured
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment27 See more
-
Chemicals and Drugs218
See more
- Amino Acids, Peptides, and Proteins 58
- Biological Factors 16
- Biomedical and Dental Materials 1
- Carbohydrates 10
- Chemical Actions and Uses 39
- Complex Mixtures 20
- Enzymes and Coenzymes 4
- Heterocyclic Compounds 67
- Hormones, Hormone Substitutes, and Hormone Antagonists 18
- Inorganic Chemicals 33
- Lipids 4
- Macromolecular Substances 1
- Nucleic Acids, Nucleotides, and Nucleosides 5
- Organic Chemicals 104
- Pharmaceutical Preparations 6
- Polycyclic Compounds 33
-
Diseases436
See more
- Bacterial Infections and Mycoses 35
- Cardiovascular Diseases 45
- Chemically-Induced Disorders 28
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 54
- Digestive System Diseases 37
- Endocrine System Diseases 46
- Eye Diseases 7
- Female Urogenital Diseases and Pregnancy Complications 36
- Hemic and Lymphatic Diseases 38
- Immune System Diseases 61
- Male Urogenital Diseases 34
- Musculoskeletal Diseases 15
- Neoplasms 83
- Nervous System Diseases 69
- Nutritional and Metabolic Diseases 80
- Otorhinolaryngologic Diseases 11
- Parasitic Diseases 10
- Pathological Conditions, Signs and Symptoms 150
- Respiratory Tract Diseases 19
- Skin and Connective Tissue Diseases 18
- Stomatognathic Diseases 8
- Virus Diseases 40
- Wounds and Injuries 8
- Health Care2 See more
- Phenomena and Processes36 See more
- Psychiatry and Psychology71 See more
- Technology, Industry, Agriculture6 See more
Search Clinical Trials
Completed
Prostate Biomarker Study (External Link)
The Inter-SPORE Prostate Biomarkers Study (IPBS) was established to prospectively collect and analyze biological specimens to predict and validate outcomes after treatment for prostate cancer. The study population will consist …
Baylor Role:
Collaborator
Completed
Improving Outcomes Using Collaborative Group Clinics to Empower Older Patients (External Link)
Among persons aged 55-84 years, over 65% have one to three common medical conditions (e.g., hypertension, diabetes, arthritis, stroke, heart disease, etc.). Fortunately, large randomized clinical trials have demonstrated the …
Baylor Role:
Lead Sponsor
Completed
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. (External Link)
Epidemiological evidence indicates that metabolic syndrome (MS) is a strong predisposing condition for atherosclerosis. Elevation of plasma low-density lipoprotein (LDL) cholesterol(LDL-C) concentration is the most important risk factor for atherosclerosis; …
Baylor Role:
Lead Sponsor
Completed
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children (External Link)
For the last 12 years, scientific evidence has mounted linking Helicobacter pylori infection with iron deficiency and iron deficiency anemia. Reports from around the world on several cases of iron …
Baylor Role:
Collaborator
Completed
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma (External Link)
Induction Phase Overview The induction phase is approximately 15 weeks long. Chemotherapy is generally given every 3 weeks, each 3 week block is called a "cycle". During these 15 weeks …
Baylor Role:
Lead Sponsor
Completed
Role of Exenatide in Type 1 Diabetes (External Link)
A large study in people with type 1 diabetes (T1DM) showed that lowering blood sugars stopped or delayed the occurrence of health problems. As a result of the study, treatment …
Baylor Role:
Lead Sponsor
Completed
Screening for Bladder Cancer (External Link)
Reduction of cancer mortality is a stated goal of the National Cancer Institute. Cancer of the bladder is the 4th most commonly diagnosed cancer and 7th leading cause of cancer …
Baylor Role:
Lead Sponsor
Completed
Does Potassium Bicarbonate Improve the Effect of Dietary Protein on Bone and Muscle? (External Link)
The balance between the amount of protein in the diet (anabolic component) and the net acid load of the diet (catabolic component) in part determines whether the diet as a …
Baylor Role:
Collaborator
Completed
Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) (External Link)
This is a Phase 1, open-label, dose-escalating study of karenitecin plus cyclophosphamide in the treatment of pediatric patients with refractory or recurrent solid tumors. All patients must have histologically documented …
Baylor Role:
Lead Sponsor
Completed
Ziprasidone in Pediatric Bipolar Disorder (External Link)
This study will enroll approximately 60 children and adolescents aged 10-17 years who have been diagnosed with bipolar disorder. Their participation will last about 8 weeks (2 weeks of screening …
Baylor Role:
Lead Sponsor